Quasi-two-dimensional (2D) perovskites have received intensive attention as a new class of luminescent materials owing to large exciton binding energy and high photoluminescence efficiency. However, there usually contains a mixture of phases in these materials, and excessive low-dimensional phase perovskite is harmful for luminescence efficiency owing to the strong exciton-phonon quenching at the room temperature. Herein, a simple and effective method is proposed to suppress the growth of low-dimensional phase components in quasi-2D perovskite film via carefully adjusting the molar ratio of cesium bromide (CsBr) and phenylpropylammonium bromide (PPABr). The device based on this optimized film has achieved a peak brightness of 2921 cd m
−2
and peak current efficiency of 1.38 cd A
−1
, far away higher than that of the pristine CsPbBr
3
device. This research proves a new way for modulating the phase composition in quasi-2D perovskites to fabricate highly efficient perovskite light-emitting diodes (PeLEDs).
In this work, we fabricate poly(vinylpyrrolidone) (PVP)-treated Ruddlesden-Popper two-dimensional (quasi-2D) PPA 2 (CsPbBr 3) 2 PbBr 4 perovskite light-emitting diodes (PeLEDs) and achieved a peak brightness of 10,700 cd m −2 and peak current efficiency of 11.68 cd A −1 , threefold and tenfold higher than that of the pristine device (without PVP), respectively. It can be attributed that the additive of PVP can suppress the pinholes of perovskite films owing to the excellent film-forming property, inhibiting the leakage current. Besides, PVP treatment facilitates the formation of compact perovskite films with defect reduction. Our work paves a novel way for the morphology modulation of quasi-2D perovskite films.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.